[HTML][HTML] lncRNA NEAT1: Key player in neurodegenerative diseases

K Li, Z Wang - Ageing Research Reviews, 2023 - Elsevier
Neurodegenerative diseases are the most common causes of disability worldwide. Given
their high prevalence, devastating symptoms, and lack of definitive diagnostic tests, there is …

[HTML][HTML] Molecular landscape of LncRNAs in bladder cancer: from drug resistance to novel LncRNA-based therapeutic strategies

A Mehmandar-Oskuie, K Jahankhani… - Biomedicine & …, 2023 - Elsevier
Bladder cancer (BC) is a common and serious type of cancer that ranks among the top ten
most prevalent malignancies worldwide. Due to the high occurrence rate of BC, the …

[HTML][HTML] Epigenetic programing of cancer stemness by transcription factors-non-coding RNAs interactions

RKME Alsayed, KSAM Sheikhan, MA Alam… - Seminars in Cancer …, 2023 - Elsevier
Cancer 'stemness' is fundamental to cancer existence. It defines the ability of cancer cells to
indefinitely perpetuate as well as differentiate. Cancer stem cell populations within a …

miRNA, lncRNA and circRNA: targeted molecules with therapeutic promises in Mycoplasma pneumoniae infection

T Gan, J Yu, J He - Archives of Microbiology, 2023 - Springer
Mycoplasma pneumoniae (MP) is primarily recognized as a respiratory pathogen that
causes community-acquired pneumonia, which can lead to acute upper and lower airway …

[HTML][HTML] DARS-AS1: A Vital Oncogenic LncRNA Regulator with Potential for Cancer Prognosis and Therapy

J Shu, K Xia, H Luo, Y Wang - International Journal of Medical …, 2024 - ncbi.nlm.nih.gov
DARS-AS1, short for Aspartyl-tRNA synthetase antisense RNA 1, has emerged as a pivotal
player in cancers. Upregulation of this lncRNA is a recurrent phenomenon observed across …

[HTML][HTML] The role of E3 ubiquitin ligases and deubiquitinases in bladder cancer development and immunotherapy

X Wang, Y Zhang, Y Wu, H Cheng, X Wang - Frontiers in Immunology, 2023 - frontiersin.org
Bladder cancer is one of the common malignant urothelial tumors. Post-translational
modification (PTMs), including ubiquitination, acetylation, methylation, and phosphorylation …

[HTML][HTML] LINC01134: a pivotal oncogene with promising predictive maker and therapeutic target in hepatocellular carcinoma

Y Yu, J Wang, Q Guo, H Luo - Frontiers in Oncology, 2024 - frontiersin.org
Hepatocellular carcinoma (HCC) represents a leading and fatal malignancy within the
gastrointestinal tract. Recent advancements highlight the pivotal role of long non-coding …

[HTML][HTML] A review on the role of gamma-butyrobetaine hydroxylase 1 antisense RNA 1 in the carcinogenesis and tumor progression

J Hu, J Liu, S Zhou, H Luo - Cancer Cell International, 2023 - Springer
Gamma-butyrobetaine hydroxylase 1 antisense RNA 1 (BBOX1-AS1), located on human
chromosome 11 p14, emerges as a critical player in tumorigenesis with diverse oncogenic …

[HTML][HTML] EPB41L4A-AS1 is required to maintain basal autophagy to modulates Aβ clearance

Z Wang, R Wang, L Niu, X Zhou, J Han, K Li - npj Aging, 2024 - nature.com
Alzheimer's disease (AD) is the most common neurodegenerative disorder characterized by
the deposition of β-amyloid (Aβ) plaques. Aβ is generated from the cleavage of the amyloid …

Competing endogenous RNAs in head and neck squamous cell carcinoma: a review

A Agrawal, V Vindal - Briefings in Functional Genomics, 2023 - academic.oup.com
Our understanding of RNA biology has evolved with recent advances in research from it
being a non-functional product to molecules of the genome with specific regulatory …